FDA approves Moderna's new lower-dose COVID-19 vaccine
The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for the company's existing shot, but a second option.
The new vaccine, mNexspike, is a step toward next-generation coronavirus vaccines. It's made in a way that allows for a lower dose — a fifth of the dose of its current COVID-19 vaccine, Spikevax — by refining its immune target.
The approval 'adds an important new tool to help protect people at high risk of severe disease from COVID-19,' Stephane Bancel, Moderna's CEO, said in a statement Saturday.
The Food and Drug Administration approved the new vaccine for use in all adults 65 and older, and for people age 12 to 64 who have a least one health condition that puts them at increased risk from the coronavirus.
That's the same limit that the FDA set in licensing another COVID-19 vaccine option from competitor Novavax.
Those restrictions are a departure from how the U.S. has handled COVID-19 vaccines until now, reflecting skepticism about vaccines from Health Secretary Robert F. Kennedy Jr. and other Trump officials.
Moderna's existing vaccine doesn't face those limits and has long been used for anyone ages 6 months and older. The company said it expected to offer both options this fall.
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective — and more by some measures — than the original shot, the company said.
The news came just days after the Trump administration canceled funding for Moderna to develop a vaccine against potential pandemic flu viruses, including the H5N1 bird flu, despite promising early study results.
___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Toronto Star
a day ago
- Toronto Star
Trump says he's withdrawing the nomination of Musk associate Jared Isaacman to lead NASA
WASHINGTON (AP) — President Donald Trump announced late Saturday that he is withdrawing the nomination of tech billionaire Jared Isaacman, an associate of Trump adviser Elon Musk, to lead NASA, saying he reached the decision after a 'thorough review' of Isaacman's 'prior associations.' It was unclear what Trump meant and the White House did not immediately respond to an emailed request for an explanation. 'After a thorough review of prior associations, I am hereby withdrawing the nomination of Jared Isaacman to head NASA,' Trump wrote on his social media site. 'I will soon announce a new Nominee who will be Mission aligned, and put America First in Space.' ARTICLE CONTINUES BELOW Trump announced in December during the presidential transition that he had chosen Isaacman to be the space agency's next administrator. Isaacman, 42, has been a close collaborator with Musk ever since buying his first chartered flight on Musk's SpaceX company in 2021. He is the CEO and founder of Shift4, a credit card processing company. He also bought a series of spaceflights from SpaceX and conducted the first private spacewalk. SpaceX has extensive contracts with NASA. The Senate Commerce, Science and Transportation Committee approved Isaacman's nomination in late April and a vote by the full Senate was expected soon. Musk appeared to lament Trump's decision after the news broke earlier Saturday, posting on the X site that, 'It is rare to find someone so competent and good-hearted.' SpaceX is owned by Musk, a Trump campaign contributor and adviser who announced this week that he is leaving the government after several months at the helm of the Department of Government Efficiency, or DOGE. Trump created the agency to slash the size of government and put Musk in charge. Semafor was first to report that the White House had decided to pull Isaacman's nomination.
CTV News
a day ago
- CTV News
‘I am NOT taking drugs!' Musk denies damning report
Elon Musk attends a news conference with President Donald Trump in the Oval Office of the White House, Friday, May 30, 2025, in Washington. (AP Photo/Evan Vucci) Elon Musk on Saturday denied a report that he used ketamine and other drugs extensively last year on the 2024 campaign trail. The New York Times reported Friday that the billionaire adviser to President Donald Trump used so much ketamine, a powerful anesthetic, that he developed bladder problems. The newspaper said the world's richest person also took ecstasy and mushrooms and traveled with a pill box last year, adding that it was not known whether Musk also took drugs while heading the so-called Department of Government Efficiency (DOGE) after Trump took power in January. In a post Saturday on X, Musk said: 'To be clear, I am NOT taking drugs! The New York Times was lying their ass off.' He added: 'I tried 'prescription' ketamine a few years ago and said so on X, so this not even news. It helps for getting out of dark mental holes, but haven't taken it since then.' Musk first dodged a question about his drug use at a bizarre farewell appearance Friday with Trump in the Oval Office in which the Tesla and SpaceX boss sported a noticeable black eye as he formally ended his role as Trump's main cost-cutter at DOGE, which fired tens of thousands of civil servants. News of the injury drew substantial attention as it came right after the Times report on his alleged drug use. The daily recalled erratic behavior such as Musk giving an enthusiastic Nazi-style salute last year. Musk said he got the injury while horsing around with his young son, named X, when he told the child to hit him in the face. 'And he did. Turns out even a five-year-old punching you in the face actually is...' he added, before tailing off. Later Friday, when a reporter asked Trump if he was aware of Musk's 'regular drug use,' Trump responded: 'I wasn't.' 'I think Elon is a fantastic guy,' he added. Musk has previously admitted to taking ketamine, saying he was prescribed it to treat a 'negative frame of mind' and suggesting his use of drugs benefited his work.
CTV News
a day ago
- CTV News
White House says it will announce new pick for NASA chief
The White House said Saturday it will announce a replacement candidate to serve as U.S. President Donald Trump's pick to lead NASA, indicating it will withdraw the nomination of tech billionaire Jared Isaacman. 'The Administrator of NASA will help lead humanity into space and execute President Trump's bold mission of planting the American flag on the planet Mars,' White House assistant press secretary Liz Huston said. 'It's essential that the next leader of NASA is in complete alignment with President Trump's America First agenda and a replacement will be announced directly by President Trump soon.' The move comes just days before the Senate was expected to vote on Isaacman's nomination to lead NASA. Isaacman, who has twice traveled to space on private missions and has close ties to SpaceX chief Elon Musk, sent shock waves through the space community when Trump first tapped him for NASA administrator in December, CNN previously reported. Isaacman's appointment was also met with broad support in the space community, which viewed him as a passionate leader, and his spaceflight experience was considered a bonus. Isaacman, the CEO of payments platform company Shift4, was viewed with deep skepticism by Democratic lawmakers concerned he would use his position at NASA to advance Musk's personal interests. The reasons behind Trump's sudden reversal were not clear. During Isaacman's confirmation hearing before the Senate Committee on Commerce, Science and Transportation in April, he signaled he would back an effort to land humans on Mars. The remarks were notable because NASA has been squarely focused on the Artemis program, which aims to return astronauts to the moon, since Trump's first term. Only since Musk became a close Trump ally in 2024 has the president vocalized an interest in human exploration of Mars, which has been Musk's longtime goal. Isaacman signaled during the April confirmation hearing that he hoped to back both the Artemis program's underlying goals as well as 'prioritize sending American astronauts to Mars.' 'Along the way (to Mars), we will inevitably have the capabilities to return to the Moon and determine the scientific, economic and national security benefits of maintaining a presence on the lunar surface,' Isaacman said. CNN has reached out to Isaacman for comment. NASA referred inquiries to the White House. Musk, who led the Department of Government Efficiency as Trump's 'first buddy,' departed the administration this week. The tech billionaire, who had recently publicly disagreed with Trump, said he'll 'remain a friend and adviser' to the president. Musk promised to refocus on SpaceX and Starship, the gargantuan rocket system that he hopes will be capable of carrying convoys of humans to Mars. Still in the early stages of development, Starship prototypes have lost control and exploded during three test flights this year, includes one on Tuesday. Semafor was first to report that the White House was likely to pull Isaacman's nomination.
